Inhibiting lung cancer by targeting disulfide reductase enzymes with a novel small molecule that induces reactive oxygen species
Inhibiting lung cancer by targeting disulfide reductase enzymes with a novel small molecule that induces reactive oxygen species
批准号:
412153
负责人:
Johnson Fraser
金额:
$0.11万
依托单位国家:
加拿大
项目类别:
财政年份:
2019
资助国家:
加拿大
项目状态:
已结题
起止时间:
2019-09-01 至 2020-09-01
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Lung cancer (LC) is the leading cause of cancer deaths worldwide, mainly due to the lack of effective drugs available. Most current therapies are focused on targeting genes mutated in lung cancer; however, tumours may require other, non-mutated genes for
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Identifying genetic factors that determine responsiveness to therapeutic HIF2a pathway inactivation in Birt-Hogg-Dubé syndrome-associated renal cell carcinoma
-
批准号:473563
-
项目类别:Fellowship Programs
-
资助金额:$10.93万
-
财政年份:2022
-
负责人:Johnson Fraser
-
依托单位:
A novel mechanism of reactive oxygen species-induced synthetic lethality in lung cancer
-
批准号:404170
-
项目类别:Studentship Programs
-
资助金额:$7.65万
-
财政年份:2018
-
负责人:Johnson Fraser
-
依托单位:
The maternal embryonic leucine zipper kinase as a therapeutic target in castration-resistant prostate cancer
-
批准号:367163
-
项目类别:Studentship Programs
-
资助金额:$1.27万
-
财政年份:2016
-
负责人:Johnson Fraser
-
依托单位:
海外基金